MedPath

Effect of Lidocaine Gel for Pain Relief during Endometrial Sampling in Postmenopausal bleeding: Randomized Controlled Trial

Phase 2
Completed
Conditions
Post menopausal bleeding
Endometrial sampling
Lidocaine jelly
Pain score
Registration Number
TCTR20231005003
Lead Sponsor
/A
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Female
Target Recruitment
72
Inclusion Criteria

women who were diagnosed with post menopausal bleeding and were literate, mature, and stable enough to do the visual analog score (VAS).

Exclusion Criteria

1.allergy to lidocaine jelly
2.unstable vital signs for example systolic blood pressure (SBP) lower than 90 mmHg., diastolic blood pressure (SBP) lower than 60 mmHg., pulse rate more than 120 bpm.,
3.patient unconsciousness or unable to answer the question and pain score.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
the pain score when finishing endometrial sampling finishing endometrial sampling VAS,the pain score when finishing the procedure for 10 min when finishing the procedure for 10 min VAS,the pain score when start endometrial sampling when start endometrial sampling VAS
Secondary Outcome Measures
NameTimeMethod
satisfied finishing the procedure for 10 min score (1-10)
© Copyright 2025. All Rights Reserved by MedPath